Trials / Completed
CompletedNCT00005864
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
A Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Colorectal Cancer Stage IV
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have stage IV colorectal cancer.
Detailed description
OBJECTIVES: I. Assess the antitumor activity and toxicities of chloroquinoxaline sulfonamide in patients with stage IV colorectal cancer. OUTLINE: This is a multicenter study. Patients receive chloroquinoxaline sulfonamide IV over 1 hour weekly for 4 consecutive weeks. Treatment continues every 6 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed for at least 30 days. PROJECTED ACCRUAL: A total of 16-25 patients will be accrued for this study within 8 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | chloroquinoxaline sulfonamide |
Timeline
- Start date
- 2000-04-01
- Completion
- 2004-02-01
- First posted
- 2004-02-25
- Last updated
- 2013-01-31
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00005864. Inclusion in this directory is not an endorsement.